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Background: Panax ginseng has been used to prolong longevity and is believed to be useful for improving
skin complexion. Ginsenosides are the most active components isolated from ginseng, and ginsenoside
Rg3 (G-Rg3) in particular has been demonstrated to possess antioxidative, antitumorigenic, and anti-
inﬂammatory properties. The aim of this study was to examine the ability of G-Rg3 to inhibit
melanogenesis.
Methods: The effects of G-Rg3 on melanin contents and the protein levels of tyrosinase, microphthalmia-
associated transcription factor (MITF), and tyrosinase-related protein 1 (TRP1) were evaluated.
Melanogenesis-regulating signaling molecules such as Akt and extracellular signal-regulated kinase
(ERK) were also examined to explore G-Rg3-induced antimelanogenic mechanisms.
Results: G-Rg3 was found to signiﬁcantly inhibit the synthesis of melanin in normal human epidermal
melanocytes and B16F10 cells in a dose-dependent manner. The activity of cellular tyrosinase and the
expression of MITF, tyrosinase, and TRP1 were all reduced, whereas ERK was strongly activated. PD98059
(a speciﬁc inhibitor of ERK) attenuated the G-Rg3-induced inhibition of melanin synthesis and tyrosinase
activity.
Conclusion: Taken together, these results showed that G-Rg3 induces the activation of ERK, which ac-
counts for its antimelanogenic effects. G-Rg3 may be a promising safe skin-whitening agent, adding to
the long list of uses of P. ginseng for the enhancement of skin beauty.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Melanin is the pigment responsible for skin and hair color that is
synthesized in melanosomes by melanocytes. Although melanin
plays an important protective role against UV light, melanin over-
production and accumulation can cause serious cutaneous
pigmentary disorders such as freckles, melasma, and age spots
[1,2]. Thus, the inhibition of melanogenesis has been the focus of
medicinal and cosmetic treatments for skin pigmentary diseases
[1,2]. Although most of previous antimelanogenesis experiments
were carried out in B16 melanoma cells, reduction of melanin ac-
tivity in human normal epidermal melanocytes should be
demonstrated to conﬁrm the effect of possible whitening agents iny, Kangbuk Samsung Hospital, Sun
gy, Asan Medical Center, Universit
g), gyleemd@gmail.com (G.-Y. Lee
ght  2015, The Korean Society ofhuman skin [3e5]. Melanogenesis is regulated by the key enzyme,
tyrosinase, and additional enzymatic proteins such as tyrosinase-
related proteins TRP1 and TRP2 [1e4]. Microphthalmia-associated
transcriptional factor (MITF) plays a critical role in the regulation
of melanin synthesis and transcription of the key enzyme tyrosi-
nase [3e5].
Panax ginseng has been commonly used as an herbal medicine in
Asia for more than 2,000 years and currently occupies an important
place among the tonic remedies used in Oriental medicine. In North
America, ginseng species such as Panax quinquefolius represent an
important industry for both the domestic and export markets [6,7].
Currently, over 40 ginsenosides have been explored and classiﬁed
into several types in accordance with their speciﬁc chemicalgkyunkwan University School of Medicine, 108 Pyeong-dong, Jongno-gu, Seoul 110-
y of Ulsan College of Medicine, 388-1 Poongnap-dong, Songpa-gu, Seoul 138-736,
).
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anolic acids [6e8]. Recently, many investigational studies have
shown that ginsenosides are biologically active components in
antioxidant, antineoplastic, anti-inﬂammatory, and biomodulatory
processes [7,9e13]. Ginsenoside Rg3 (G-Rg3), a tetracyclic tri-
terpenoid saponin monomer, is the primary bioactive component
of ginseng extract and has been reported to have various biological
effects, including antioxidant effects that may inﬂuence melano-
genesis [7,8,14,15]. However, the inhibitory effect of G-Rg3 on
melanogenesis has not been reported to date. In this study, we have
evaluated the inhibitory effect of G-Rg3 on melanin biosynthesis in
B16F10 cells and normal human melanocytes. In addition, the
molecular mechanisms underlying the antimelanogenic action of
G-Rg3 were further evaluated.
2. Materials and methods
2.1. Chemicals and antibodies
Arbutin, alpha-melanocyte-stimulating hormone (a-MSH), L-
3,4-dihydroxyphenylalanine (L-DOPA), 3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyltetrazolium bromide (MTT), and PD98059 were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies
recognizing phospho-extracellular signal-regulated kinase (p-ERK,
No. 9101) and phospho-AKT (p-AKT, No. 9271) were obtained from
Cell Signaling Technology (Danvers, MA, USA). Antityrosinase (H-
109), TRP1 (H-90), MITF (H-50), and actin (H-300) antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
2.2. Cell culture and cell viability assay
B16F10 mouse melanoma cells (CRL 6475) were obtained from
the American Type Culture Collection (Manassas, VA, USA) and
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mentedwith 10% fetal bovine serum and 1% penicillin/streptomycin
in a humidiﬁed atmosphere containing 5% CO2 at 37C. Normal
human melanocytes (neonatal/moderately pigmented) were
cultured in medium 254 supplemented with human melanocyte
growth supplement (Cascade Biologics, Invitrogen, Carlsbad, CA,
USA). Melanocytes at between three and seven passages were used
for analysis. The melanocyte culture was fed two times weekly and
incubated in a humidiﬁed atmosphere at 37C and 5% CO2.
After incubating the cells with 20, 40, 60, 80, or 100mM of G-Rg3
for 48 h at 37C in an atmosphere containing 5% CO2, MTT was
added to each well at one tenth of the volume of media. The cells
were incubated at 37C for 3 h, and dimethyl sulfoxide (DMSO) was
added to dissolve the formazan crystals. Absorbance was measured
at 570 nm using a spectrophotometer.
2.3. Measurement of melanin content
Normal human melanocytes and B16F10 cells were pretreated
with various concentrations (20, 40, and 60mM) of G-Rg3 or with
50 mg/mL arbutin control for 72 h. Cell pellets were then dissolved
in a 200 mL aliquot of 1N NaOH in 10% DMSO at 100C for 30 min
and centrifuged at 13,000 rpm for 10 min. The relative melanin
content was measured using a microplate reader at 415 nm. The
value of each measurement is expressed as a percentage change
from the control.
2.4. Tyrosinase activity assay
Tyrosinase activity was estimated by measuring the rate of
dopachrome formation from L-DOPA. Cells grown in six-well plates
were treated with 200nM a-MSH in the presence of 20, 40, or 60mMG-Rg3 or 50 mg/mL arbutin (control) in DMEM for 72 h. The cells
were then washed in ice-cold phosphate-buffered saline and lysed
in 150 mL of sodium phosphate buffer (0.1M, pH 6.8) containing
0.5% Triton X-100 and 0.1mM phenylmethanesulfonyl ﬂuoride. The
cellular extract was centrifuged at 13,000 rpm for 20 min at 4C.
The tyrosinase substrate, 10 mL of 10mM L-DOPA, was added to
90 mL of the supernatant sample. Dopachrome formation was
assayed by measuring the absorbance at 492 nm.
2.5. Western blot analysis
B16F10 cells were cultured in 60-mm diameter dishes with or
without 200nM a-MSH and 20, 40, or 60mM G-Rg3. Cell pellets
were harvested and lysed using radioimmunoprecipitation assay
lysis buffer (EMD Millipore, Billerica, MA, USA). The samples were
resolved by 4e20% gradient sodium dodecyl sulfateepoly-
acrylamide gel electrophoresis, transferred to polyvinylidene ﬂuo-
ride membranes, and then exposed to the appropriate primary
antibodies such as MITF, tyrosinase, TRP1, p-ERK, p-AKT, and b-
actin. The proteins were visualized by an enhanced chem-
iluminescence system (Amersham Biosciences, Piscataway, NJ,
USA) using horseradish peroxidase-conjugated antirabbit second-
ary antibodies.
2.6. Statistical analysis
The data in this report are representative of three or more ex-
periments under same conditions and are expressed as the
mean  standard error of the mean. Differences between means
were tested for signiﬁcance by one-way analysis of variance test
using a statistical software package (SPSS version 18.0; SPSS Inc.,
Chicago, IL, USA). A p value of less than 0.05 was considered sta-
tistically signiﬁcant.
3. Results
3.1. Effects of G-Rg3 on cell viability
To exclude the possibility that the inhibitory effects of G-Rg3 on
melanogenesis are caused by suppression of cell growth, a cell
viability test was performed. Treatment with G-Rg3 at concentra-
tions ranging from 20 to 60mM had no cytotoxic effect in B16F10
cells. Based on these results, G-Rg3 concentrations in the range of
20e60mM were used for the remainder of the experiments. In
normal human melanocyte, no signiﬁcant changes in cell viability
were found at concentrations as high as 40mM G-Rg3, and more
than 80% of cells were alive at 60mM G-Rg3 concentration (Fig. 1).
3.2. Inhibition of melanin biosynthesis and tyrosinase activity
To investigate the antimelanogenic mechanism of G-Rg3, cells
were exposed to tyrosinase inhibitors a-MSH (200nM) or arbutin
(50 mg/mL) in the presence of G-Rg3 (20e60mM), and subsequently,
the melanin content and cellular tyrosinase activity of cells were
measured. The melanin content was found to be remarkably
reduced by the G-Rg3 treatment in a dose-dependent manner in
both B16F10 cells (Fig. 2A) and normal human melanocytes
(Fig. 2B). At concentration  40mM, G-Rg3 caused a signiﬁcant
reduction in melanin content in normal human melanocytes
(Fig. 2B). Tyrosinase activity also showed a consistent and dose-
dependent decrease in response to the G-Rg3 treatment (Fig. 2A).
The melanin content and tyrosinase activity in the 60mM G-Rg3-
treated and arbutin-treated cells were signiﬁcantly lower than
those in a-MSH-treated cells (p < 0.05). Moreover, the melanin
content and tyrosinase activity in 60mM G-Rg3-treated cells were
Fig. 1. Cell viability assay after ginsenoside Rg3 (G-Rg3) treatment in normal human
melanocytes. After incubating cells with 20, 40, or 60mM of G-Rg3 for 48 h at 37C in an
atmosphere containing 5% CO2, 3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide was added to each well at one tenth of the volume of media. Data are
expressed as the mean  standard error of the mean of three independent experi-
ments carried out in triplicate. CON, control cells.
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These results indicate that G-Rg3 inhibits tyrosinase activity and
melanin production without affecting the cellular viability. More-
over, the inhibitory activity of G-Rg3 on melanogenesis is due to
inhibition of the melanogenesis pathway involving the key mela-
nogenesis enzyme, tyrosinase.Fig. 2. (A) Inhibitory effect of ginsenoside Rg3 (G-Rg3) on melanin synthesis and cellular tyro
200nM alpha-melanocyte-stimulating hormone (a-MSH) in the presence of G-Rg3 (20, 40, o
In normal human melanocytes, G-Rg3 inhibited melanin contents in a dose-dependent man
cells (CON; i.e., normal human melanocytes without a-MSH). Data are expressed as the m
triplicate. * p < 0.05 compared with a-MSH-treated cells.3.3. Effects of G-Rg3 on melanogenic protein expression and
intracellular signaling involved in melanogenesis
To determine whether the inhibitory activity of G-Rg3 is related
to the melanogenesis pathways involving MITF, tyrosinase, and
TRP1, B16F10 cells were treated with G-Rg3, followed by stimula-
tion with a-MSH for 48 h. The cells were then analyzed byWestern
blot analysis. The protein levels of MITF, tyrosinase, and TRP1 in a-
MSH-stimulated cells decreased following treatment with G-Rg3
(Fig. 3A). The decreased expression levels of MITF, tyrosinase, and
TRP1 were most prominent following treatment with 60mMG-Rg3,
consistent with the melanin content and tyrosinase activity mea-
surements. These results indicate that G-Rg3 suppresses the
expression of tyrosinase protein by downregulating the expression
of MITF, a master transcription factor of the tyrosinase gene.
As for the intracellular signaling, ERK and/or Akt activation is
well-known to be involved in the regulation of melanogenesis. We
then investigated the effects of G-Rg3 on the ERK and AKT signaling
pathways. Akt signalingwas activated inconsistently. The activation
of p-ERK was induced by the G-Rg3 treatment, most notably at
concentrations of 40 and 60mM (Fig. 3A). Moreover, serial time-
dependent blotting of ERK activation revealed that p-ERK levels
were markedly increased 48 h after the a-MSH treatment (Fig. 3B).
These results suggest that the suppressive mechanism of G-Rg3 in
melanogenesis is related to the activation of ERK signaling.3.4. Role of the ERK pathway in the inhibition of melanin synthesis
We cultured B16F10 cells with or without PD98059 (a speciﬁc
inhibitor of the ERK pathway) for 72 h to determine whether G-Rg3sinase activity in B16F10 cells. For the cellular tyrosinase activity, cells were exposed to
r 60mM) or arbutin (50 mg/mL) as a positive control for tyrosinase inhibition for 72 h. (B)
ner. Each value for the treated cells is reported as a percentage relative to the control
ean  standard error of the mean of three independent experiments carried out in
Fig. 3. (A) Effect of ginsenoside Rg3 (G-Rg3) on the expression of melanogenesis-
related proteins and intracellular signaling proteins in B16F10 cells. Cells were
exposed to 200nM alpha-melanocyte-stimulating hormone (a-MSH) at different doses
of G-Rg3 (20, 40, and 60mM) for 48 h. The control cells (CON) were without a-MSH. The
protein expression levels of tyrosinase, tyrosinase-related protein 1 (TRP1),
microphthalmia-associated transcription factor, phospho-extracellular signal-regu-
lated kinase (p-ERK), and p-AKT were then examined by Western blot analysis.
Normalization for loading differences in densitometry values was carried out using b-
actin. (B) Time-dependent effect of G-Rg3 on the expression of tyrosinase and p-ERK
during the incubation period. Cells were exposed to 60mM G-Rg3 for the indicated
times with 200nM a-MSH stimulation, and the protein expression levels of tyrosinase
and p-ERK were examined by Western blot analysis. Normalization for loading dif-
ferences in densitometry values was carried out using b-actin. Note the distinct
changes in expression levels of the tyrosinase and p-ERK proteins at 48 and 72 h.
Fig. 4. Effects of PD98059 on melanin synthesis (A) and cellular tyrosinase activity (B)
in ginsenoside Rg3 (G-Rg3)-treated B16F10 cells. Cells were exposed to 200nM alpha-
melanocyte-stimulating hormone (a-MSH) after pretreatment with or without G-Rg3
(60mM) and PD98059 (20mM). Each treated cell is reported as a percentage relative to
that in a-MSH-treated control cells. Data are reported as the mean  standard error of
the mean of three independent experiments carried out in triplicate. * p < 0.05
compared with a-MSH and G-Rg3 co-treated cells.
S.J. Lee et al / Antimelanogenic effect of G-Rg3 241inhibits melanogenesis through the ERK pathway. Treatment with
PD98059 inhibited the G-Rg3-induced antimelanogenic effect in a-
MSH-stimulated cells and led to the recovery of tyrosinase activity
and melanin content. The melanin content and tyrosinase activities
of cells co-treated with G-Rg3 and a-MSH were signiﬁcantly
increased following treatment with PD98059 (p < 0.05, Fig. 4).
These results suggest that G-Rg3-mediated ERK activation con-
tributes to reduced melanin synthesis through MITF and its
downstream expression of tyrosinase and TRP1.4. Discussion
The abnormal production and accumulation of melanin on the
exposed area such as the face and neck are characteristic of several
common hyperpigmentation disorders such as melasma, post-
inﬂammatory hyperpigmentation, freckles, uneven skin tone, and
solar lentigo. These skin disorders can pose a serious esthetic prob-
lem for many people, especially for those in Asian countries.
Although many pharmacological skin-whitening agents such as hy-
droquinone, arbutin, kojic acid, vitamin C, retinol, and azelaic acid,
and numerous botanical compounds are available, there is a great
interest in identifying other natural skin-whitening agents for safe
application [6,16e18]. Although hydroquinone has been themainstay treatment for hyperpigmentation, its clinical potential has
been complicated bya numberof adverse reactions including contact
dermatitis, irritation, transient erythema, burning or prickling sen-
sations, leukoderma, chestnut spots on the nails, hypochromia, and
ochronosis [1,19e22]. As a result, many studies have been conducted
in attempts to develop new and safe skin-whitening agents.
Today, natural extracts are a valuable resource for the develop-
ment of new drugs. Ginseng, which refers to the root of P. ginseng
and its related species, has been used for thousands of years in Asian
countries and exhibits a wide range of medicinal effects [10e14,23].
The pharmacological effects of ginseng have been demonstrated in
the central nervous system as well as in the cardiovascular, endo-
crine, and immune systems [15,24e28]. In addition, ginseng and its
constituents have been ascribed to have antineoplastic, antistress,
and antioxidant activities [27e30]. The herb ginseng has many
active components, and numerous studies have suggested that
ginseng has a variety of beneﬁcial effects. The active constituents
found in most ginseng species are ginsenosides, polysaccharides,
peptides, polyacetylenic alcohols, and fatty acids. However, most of
the pharmacological actions of ginseng are attributed to ginseno-
sides [7,15,24,27e30]. Approximately 40 ginsenoside compounds
have been identiﬁed to date, each having different pharmacological
effects and underlying mechanisms due to their different chemical
structures. Based on their chemical structures, the ginsenosides are
generally classiﬁed into two groups, namely, the protopanaxadiols
and protopanaxatriol groups. The sugar moieties in the proto-
panaxadiol group attach to position 3 of dammarane-type triterpene
such as in Rb1, Rb2, Rc, Rd, Rg3, Rh2, and Rh3, whereas the sugar
J Ginseng Res 2015;39:238e242242moieties in the protopanaxatriol group attach to position 6 of
dammarane-type triterpene such as in Re, Rf, Rg1, Rg2, and Rh1.
Among these compounds, the most commonly studied ginsenosides
are Rb1, Rg1, Rg3, Re, Rd, and Rh1 [25e27,30].
G-Rg3, a tetracyclic triterpenoid saponin monomer, is one of the
most active ingredients found in ginseng extracts and is reported to
possess various biological effects such as antineoplastic, anti-
inﬂammatory, antistress, and antioxidant activities [7,8,14,15,24]. G-
Rg3 exerts protective effects attributed to its antioxidant ability by
increasing cellular antioxidant enzyme levels and acting as a free-
radical scavenger. Moreover, G-Rg3 has been shown to have the
strongest antioxidant activity among all ginsenosides [25,26,30].
Oxidative stress caused by excess reactive oxygen species and ul-
traviolet light is causally linked to skin disorders. Inhibition of reac-
tive species and scavenging of reactive species are thought to reduce
hyperpigmentation [28,29]. Antioxidants, such as ascorbic acid de-
rivatives and a-tocopherol, may prevent or delay pigmentation [29].
Because of these potential roles, we hypothesized that G-Rg3
may possess an antimelanogenic effect. To date, there have been no
reported scientiﬁc studies addressing this possibility. Therefore, we
investigated the inhibitory effects of G-Rg3 on a-MSH-induced
melanogenesis and the possible underlyingmolecularmechanisms.
Melanogenesis is regulated by various intracellular signaling
mechanisms by the action of protein kinases such as cyclic aden-
osine monophosphate-dependent protein kinase A, protein kinase
C-a, protein kinase C-b, mitogen-activated protein kinase, and
phosphatidylinositol 3-kinase (PI3K). Among these, ERKwas shown
to regulate the expression and function of melanogenic enzymes
andMITF [5,31]. Moreover, inhibition of the ERK pathway in B16F10
melanoma cells leads to hyperpigmentation by the upregulation of
tyrosinase activity and cellular differentiation. In addition, the
PI3K/Akt signaling pathway downregulates the expression of MITF
and causes antimelanogenic effect [1,18e21].
Previous studies have also shown that tyrosinase, TRP1, and
TRP2 are regulated by MITF, which is downregulated by both ERK
and AKT activation [1,19e21]. Our present results show that G-Rg3
downregulates the expression of MITF, tyrosinase, and TRP1, lead-
ing to a reduction in the activity of cellular tyrosinase and melanin
content. Furthermore, G-Rg3 induces the phosphorylation of ERK;
however, the addition of PD98059, a speciﬁc inhibitor of the ERK
pathway, attenuates the G-Rg3-induced inhibition of melanin
synthesis and tyrosinase activity. Taken together, G-Rg3 inhibits
melanogenesis by activating the ERK pathway-mediated suppres-
sion of MITF and downstream signaling molecules such as tyrosi-
nase and TRP1. To our knowledge, this is the ﬁrst report on the
inhibitory effects of G-Rg3 on melanin production. These results
indicate that G-Rg3 is a potential new and safe skin-whitening
agent for enhancing skin beauty and for the treatment of hyper-
pigmentation disorders.
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